Oragenics, Inc.
AMEX: OGEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Janet Huffman
- Employees
- 3
- Headquarters
- Tampa, United States
- IPO year
- 2004
- Market cap
- $2.5M
- Website
- https://www.oragenics.com
Loading OGEN…
Loading profile data…Frequently asked questions about OGEN
What does Oragenics, Inc. (OGEN) do?
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2): NT-CoV2-1, an intranasal formulation, and Terra CoV-2, an intramuscular option. B...
Where does OGEN trade?
Oragenics, Inc. (OGEN) trades on the New York Stock Exchange American.
What sector is OGEN in?
Oragenics, Inc. (OGEN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oragenics, Inc.?
Janet Huffman is the chief executive officer of Oragenics, Inc. (OGEN).
Where is Oragenics, Inc. headquartered?
Oragenics, Inc. is headquartered in United States.
Does OGEN pay a dividend?
Oragenics, Inc. (OGEN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OGEN go public?
Oragenics, Inc. (OGEN) completed its initial public offering in 2004.